Plasma galectin-3 levels do not differ in systemic lupus erythematosus patients.
To investigate the plasma galectin-3 levels in systemic lupus erythematosus (SLE) patients and its relations with clinical and laboratory features. A total of 180 subjects with 90 patients with SLE (8 male, 82 female, mean age 37.86 ± 13.98 years) and 90 healthy controls (8 male, 82 female, mean age 36.54 ± 10.89 years) were included. Plasma galectin-3 levels were detected by enzyme-linked immunosorbent assay (ELISA). There was no significant difference in age and gender distribution between SLE patients and healthy controls (both P > .05). Plasma galectin-3 level was not significantly different between SLE patients and controls (P = .982) (P > .05). No significant difference was found regarding galectin-3 levels between SLE with nephritis and those without nephritis (P > .05); no significant difference was found between less active SLE and more active SLE (P > .05). Galectin-3 levels were inversely related to immune globulin M (r = -.303, P < .05), while no significant correlation between galectin-3 levels and other quantitative laboratory parameters were observed (all P > .05). In summary, plasma galectin-3 level was not significantly different between SLE patients and controls (P = .982). Further studies are needed to elucidate the role of galectin-3 in SLE.